Astellas Pharma (South Korea)
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (South Korea), South Korea, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
72%
Total
Publications
57
Total Open
Publications
41
Total
Citations
522
Open Access
Percentage
72%
Total
Publications
57
Total Open
Publications
41
Total
Citations
522
Breakdown
Publisher Open
36%
Both
32%
Other Platform Open
4%
Closed
28%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 74%
28
Hybrid 18%
7
No Guarantees 8%
3
Other Platform Open
Domain 60%
12
Institution 45%
9
Other Internet 10%
2
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 12 |
Yonsei University | Institution | 4 |
DOI | Other Internet | 2 |
aecid.es OAI-PMH Repository | Institution | 2 |
University of Alicante | Institution | 1 |
Universitat Autònoma de Barcelona | Institution | 1 |
Ludwig-Maximilians-Universität München | Institution | 1 |
European Organization for Nuclear Research | Institution | 1 |